Back to Search
PHILLIP VIGNERI, DO
DO
Radiation Oncology Physician
NPI: 1669445110Individual
Specialties, Licenses & Credentials
Research & Publications (20)
Re: Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
PMID 19546433·J Natl Cancer Inst·2009
7-preclinical
Successful Nilotinib therapy in an imatinib-resistant chronic myeloid leukemia patient displaying an intron-derived insertion/truncation mutation in the BCR-ABL kinase domain.
PMID 19406471·Leuk Res·2009
5-case
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.
PMID 19363292·J Clin Invest·2009
7-preclinical
DeltaNp73alpha inhibits PTEN expression in thyroid cancer cells.
PMID 19173293·Int J Cancer·2009
7-preclinical
Nuclear entrapment of BCR-ABL by combining imatinib mesylate with leptomycin B does not eliminate CD34+ chronic myeloid leukaemia cells.
PMID 19151780·Leukemia·2009
8-other
Imatinib dose escalation to achieve molecular responses in patients with chronic myeloid leukemia in late chronic phase.
PMID 19036439·Leuk Res·2009
8-other
Sequential mutations causing resistance to both Imatinib Mesylate and Dasatinib in a chronic myeloid leukaemia patient progressing to lymphoid blast crisis.
PMID 17889935·Leuk Res·2008
5-case
Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfolded.
PMID 17211892·Proteins·2007
8-other
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.
PMID 16618750·Cancer Res·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 300 COMMUNITY DR
MANHASSET, NY 11030 - Phone
- (516) 562-4815
Quick Facts
- NPI
- 1669445110
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile